It launched a combination drug Vildanat M (Vildagliptin and Metformin) for diabetes, to achieve better blood glucose control and improve therapy compliance.During the period 2019-20, NATCO Life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback